Marta Capelan
Sutton Upon Derwent, ENG SM25PT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Journal: Nature communications
Published: November 14, 2022
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Journal: Nature communications
Published: February 22, 2021
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months.
Journal: Oncology and therapy
Published: July 13, 2020
The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancer.
Journal: British journal of cancer
Published: February 26, 2017
Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 25, 2017
Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
Journal: Journal of translational medicine
Published: October 13, 2016
Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 03, 2016
Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population.
Journal: Breast (Edinburgh, Scotland)
Published: April 28, 2016
Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: November 24, 2015
Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials.
Journal: British journal of cancer
Published: June 22, 2015
Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 18, 2014
Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 25, 2014
Last Updated: 09/26/2026